Press Releases
 
Platelet Rich Plasma and Stem Cell Alopecia Treatment Market is projected to expand at a CAGR of 4.7

, 19 April 2019 -- Transparency Market Research (TMR) has published a new report titled, “Platelet Rich Plasma and Stem Cell Alopecia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.According to the report, the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market was valued at US $ 412.6 Mn in 2017. It is projected to expand at a CAGR of 4.7% during the forecast period. Factors such as rise in number of surgical procedures and an increase in prevalence of chronic diseases that require surgical procedures are driving the Platelet Rich Plasma and Stem Cell Alopecia Treatment market. Moreover, factors such as increased healthcare spending and medical tourism are propelling the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market. North America is expected to dominate the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market due to the presence of major players and an increase in the number of surgical procedures. Latin America and Asia Pacific are potential markets for Platelet Rich Plasma and Stem Cell Alopecia Treatment. The market in Asia Pacific is expected to expand at a CAGR of 5.2% during the forecast period.

Read Report Overview:
https://www.transparencymarketresearch.com/platelet-rich-plasma-stem-cell-alopecia-treatment-market.html

Rise in Awareness about Platelet Rich Plasma Therapies and Stem Cell Therapies is Propelling the Global Alopecia Treatment Market

The global platelet rich plasma & stem cell alopecia treatment market is expanding at a high growth rate, driven by an increase in awareness about platelet rich plasma & stem cell therapies for treating many types of alopecia. The prevalence of various types of hair loss is increasing rapidly across the world, due to a rise in the geriatric population, anxiety, vaccination, side effects of drugs, etc.. A rise in the incidence of autoimmune hair loss disorders such as alopecia is boosting the platelet rich plasma & stem cell alopecia treatment market. According to a report in the International Journal of Endocrinology and Metabolism, 2013, female pattern hair loss (FPHL), which is also known as female androgenetic alopecia, is a common condition afflicting millions of women across the world.

Increase in Funding for Alopecia Treatment Research and Stem Cell Research

Stem cells hold promise for the treatment and cure of more than 70 major diseases, including alopecia and other conditions that affect millions of people worldwide. Several private and government organizations are supporting funding for stem cell research. According to Change.org, Inc., in the U.S., 64% of people support federal funding of research on the treatment of chronic diseases using stem cells taken from human embryos. Internationally, stem cell research is supported by significant government investments, with Asia being one of the most favorable regions. Stem cell research funding by the National Institutes of Health (NIH) has increased 17% from US$ 1.2 Bn in 2013 to US$ 1.5 Bn in 2016. In 2017, nonprofit organization Alopecia UK donated US$ 0.6 Mn to the University of the West of Scotland for the development of early treatment to prevent the progression of alopecia areata. Research conducted by the university aims at developing a treatment for alopecia areata using a nonchemical stem-cell based technology based on nanovibrations known as nanokicking.

North America Dominates the Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market owing to a Rise in Technological Advancements and Prevalence of Alopecia

North America dominates the global platelet rich plasma & stem cell alopecia treatment market, owing to technological advancements, investments in research & development, and developed health care infrastructure. As per research, in 2015, 21% of women suffered from alopecia in the U.S, which supports the fact that alopecia has a higher prevalence in the country. Moreover, development of innovative products and increase in demand for products among the population in the region are contributing factors for the dominance of North America in the platelet rich plasma & stem cell alopecia treatment market.

Expansion in the Contract Research Industry Offers Significant Opportunities for Companies to Invest in Clinical Trials for Alopecia Treatment

Small and large biopharmaceutical companies have become increasingly reliant on contract research organizations (CRO) and other clinical services specialists to provide research services for their R&D operations. There are numerous government-funded medical and pharmaceutical institutions, with state-of the-art facilities, that can serve as ideal centers for multicentered clinical trials. Companies are expanding their footprints in developing countries, mainly in Asia Pacific. R&D costs in India are substantially lower as compared to those in developed countries. It is possible to conduct both new drug discovery research and novel drug delivery system programs at competitive rates. India offers cost efficiency, as the cost of conducting a trial in the country is 50% to 75% lower compared to that in the U.S. or the European Union.

Investments, Mergers & Acquisitions, and PARTNERSHIPS by Key Players are Driving the Platelet Rich Plasma & Stem Cell Alopecia Treatment Market

Request Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=55800

Key players dominating the global platelet rich plasma & stem cell alopecia treatment market are Kerastem, Eclipse, Regen Lab SA, STEMCELL Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy. Major players are focusing on mergers and acquisitions and are investing in the development of platelet rich plasma & stem cell alopecia treatment and making them available to the patient population. For instance, companies such as Stemcell technologies, Inc. highly focus on partnerships with research institutes to develop new advanced products. In 2019, Kerastem signed a partnership agreement with Myungmoon Bio Co., Ltd., a South Korea-based health care company focused on bringing innovative regenerative therapies.

About us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/



# # #


Submitted by hawer on Friday, 19 April 2019 at 2:26 AM
Category: Health Care & Medical
 
Related News

Fitness Freaks Introduces Discounted Fitness Jewellery for Men & Women
Monday, 27 May 2019

DNA Forensic Market to Witness Robust Expansion throughout the Forecast 2017 to 2025
Monday, 27 May 2019

Hypoparathyroidism Treatment Market Global Competitive Analytics and Insights 2025
Monday, 27 May 2019

Inadequately Controlled Type-II Diabetes Treatment Market To Grow In The Forecast Period 2017 - 2025
Monday, 27 May 2019

Expression Proteomics Market Demonstrates A Spectacular Growth By 2024 Available In New Report
Monday, 27 May 2019

Related Events

87th EAS Congress Maastricht May 26-29 2019
Sunday, 26 May 2019

ESDPPP 2019 - Developmental Perinatal and Pediatric Pharmacology Congress
Tuesday, 28 May 2019

DIP Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy
Wednesday, 29 May 2019

EUROSON 2019 - 31st Congress of the EFSUMB
Wednesday, 29 May 2019

52nd Annual Advances and Controversies in Clinical Pediatrics
Thursday, 30 May 2019

Latest News

State and Country Pest Control, Australia Leading Pest Control Releases Bed bugs Tips
Monday, 27 May 2019

Ground Yellow Mustard Market: Lucrative Opportunities Helps to Flourish Industry Rapidly
Monday, 27 May 2019

Rent sailboat or Motor yacht charter
Monday, 27 May 2019

Fitness Freaks Introduces Discounted Fitness Jewellery for Men & Women
Monday, 27 May 2019

DNA Forensic Market to Witness Robust Expansion throughout the Forecast 2017 to 2025
Monday, 27 May 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Monday, 27 May 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 87th EAS Congress Maastricht May 26-29 2019
  • RISC2019, INTERNATIONAL CONFERENCE FOR SCHOOL AT ROME ITALY
  • ESDPPP 2019 - Developmental Perinatal and Pediatric Pharmacology Congress
  • Intel OpenVino Workshop - Milan
  • Fixed Income Leaders Summit in Hong Kong - May 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.